These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17505002)

  • 41. Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer.
    Cho KS; Lee JS; Cho NH; Park K; Ham WS; Choi YD
    Prostate; 2008 Jun; 68(8):803-8. PubMed ID: 18302229
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
    Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
    Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
    Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
    J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
    Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
    Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
    Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
    BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
    Nose N; Sugio K; Oyama T; Nozoe T; Uramoto H; Iwata T; Onitsuka T; Yasumoto K
    J Clin Oncol; 2009 Jan; 27(3):411-7. PubMed ID: 19064969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
    Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
    J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic relevance of increased angiogenesis in osteosarcoma.
    Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
    Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome.
    Baldini N; Scotlandi K; Barbanti-Bròdano G; Manara MC; Maurici D; Bacci G; Bertoni F; Picci P; Sottili S; Campanacci M
    N Engl J Med; 1995 Nov; 333(21):1380-5. PubMed ID: 7477118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
    Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post operative infection and increased survival in osteosarcoma patients: are they associated?
    Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
    Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibular osteosarcomas: contaminated margins may not impact survival.
    Schneiderbauer MM; Gullerud R; Harmsen WS; Scully SP
    Clin Orthop Relat Res; 2007 Mar; 456():182-7. PubMed ID: 16967031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
    Psyrri A; Kassar M; Yu Z; Bamias A; Weinberger PM; Markakis S; Kowalski D; Camp RL; Rimm DL; Dimopoulos MA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8637-43. PubMed ID: 16361548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression.
    Oda Y; Wehrmann B; Radig K; Walter H; Röse I; Neumann W; Roessner A
    Gen Diagn Pathol; 1995 Oct; 141(2):97-103. PubMed ID: 8548600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods?
    Dei Tos AP; Ellis I
    Eur J Cancer; 2005 Jul; 41(10):1383-92. PubMed ID: 15919198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
    Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
    Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
    Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
    Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx.
    Leong JL; Loh KS; Putti TC; Goh BC; Tan LK
    Laryngoscope; 2004 Jan; 114(1):153-7. PubMed ID: 14710013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.